Abstract:The release of hormones from thyroxine-binding globulin (TBG) and corticosteroid-binding globulin (CBG) is regulated by movement of the reactive center loop in and out of the β-sheet A of the molecule. To investigate how these changes are transmitted to the hormone-binding site, we developed a sensitive assay using a synthesized thyroxine fluorophore and solved the crystal structures of reactive loop cleaved TBG together with its complexes with thyroxine, the thyroxine fluorophores, furosemide, and mefenamic acid. Cleavage of the reactive loop results in its complete insertion into the β-sheet A and a substantial but incomplete decrease in binding affinity in both TBG and CBG. We show here that the direct interaction between residue Thr342 of the reactive loop and Tyr241 of the hormone binding site contributes to thyroxine binding and release following reactive loop insertion. However, a much larger effect occurs allosterically due to stretching of the connecting loop to the top of the D helix (hD), as confirmed in TBG with shortening of the loop by three residues, making it insensitive to the S-to-R transition. The transmission of the changes in the hD loop to the binding pocket is seen to involve coherent movements in the s2/3B loop linked to the hD loop by Lys243, which is, in turn, linked to the s4/5B loop, flanking the thyroxine-binding site, by Arg378. Overall, the coordinated movements of the reactive loop, hD, and the hormone binding site allow the allosteric regulation of hormone release, as with the modulation demonstrated here in response to changes in temperature. The release of hormones from thyroxine-binding globulin (TBG) and corticosteroid-binding globulin (CBG) is regulated by movement of the reactive center loop in and out of the β-sheet A of the molecule. To investigate how these changes are transmitted to the hormone-binding site, we developed a sensitive assay using a synthesized thyroxine fluorophore and solved the crystal structures of reactive loop cleaved TBG together with its complexes with thyroxine, the thyroxine fluorophores, furosemide, and mefenamic acid. Cleavage of the reactive loop results in its complete insertion into the β-sheet A and a substantial but incomplete decrease in binding affinity in both TBG and CBG. We show here that the direct interaction between residue Thr342 of the reactive loop and Tyr241 of the hormone binding site contributes to thyroxine binding and release following reactive loop insertion. However, a much larger effect occurs allosterically due to stretching of the connecting loop to the top of the D helix (hD), as confirmed in TBG with shortening of the loop by three residues, making it insensitive to the S-to-R transition. The transmission of the changes in the hD loop to the binding pocket is seen to involve coherent movements in the s2/3B loop linked to the hD loop by Lys243, which is, in turn, linked to the s4/5B loop, flanking the thyroxine-binding site, by Arg378. Overall, the coordinated movements of the reactive loop, hD, and the hormone binding site allow the allosteric regulation of hormone release, as with the modulation demonstrated here in response to changes in temperature.

Towards Engineering Hormone-Binding Globulins As Drug Delivery Agents

Chemical Remodeling Cell Surface Glycans for Immunotargeting of Tumor Cells

Rational Engineering of Cytosolic Delivery Systems for Protein Therapeutics

The S-to-R Transition of Corticosteroid-Binding Globulin and the Mechanism of Hormone Release.

Allosteric Modulation of Hormone Release from Thyroxine and Corticosteroid-binding Globulins

Bioorthogonal supramolecular cell-conjugation for targeted hitchhiking drug delivery

Design of an allosterically modulated doxycycline and doxorubicin drug-binding protein

Engineering stable and non-immunogenic immunoenzymes for cancer therapy via in situ generated prodrugs

Endocytosis‐independent and Cancer‐selective Cytosolic Protein Delivery via Reversible Tagging with LAT1 substrate

Crosslinked Protein Delivery Strategy with Precise Activity Regulation Properties for Cancer Therapy and Gene Editing

Temperature-Responsive Release of Cortisol from Its Binding Globulin: A Protein Thermocouple

Using N-(2-hydroxypropyl)methacrylamide Copolymer Drug Bioconjugate As a Novel Approach to Deliver a Bcl-2-targeting Compound HA14-1 in Vivo

Robust Strategy for Antibody-Polymer-Drug Conjugation: Significance of Conjugating Orientation and Linker Charge on Targeting Ability.

Hydrophilic Small Molecules That Harness Transthyretin To Enhance the Safety and Efficacy of Targeted Chemotherapeutic Agents

Novel Drug Delivery Systems Tailored for Improved Administration of Glucocorticoids

Leveraging Engineering of Cells for Drug Delivery

Protein superglue inspired in-situ one-step site-specific immobilization of beta2-adrenoceptor and its application in bioactive compound screening from Cortex Magnoliae Officinalis

Building bioorthogonal click-release capable artificial receptors on cancer cell surface for imaging, drug targeting and delivery

Tailoring Hyperbranched Poly(β-amino ester) as a Robust and Universal Platform for Cytosolic Protein Delivery

Biocompatible coupling of therapeutic fusion proteins to human erythrocytes

Albumin-based drug delivery: harnessing nature to cure disease